A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

“While others back into the future, we lead the way forward—with curiosity, with science, with knowledge, but also compassion as our guiding star,” said Aida Hadžialić, Finance Regional Councilor and Chair of the Regional Executive Board in Region Stockholm, at the inauguration.

More than 600 participants from industry, academia, municipalities, and society gathered in Flemingsberg to celebrate the shared goal: accelerating the development and accessibility of tomorrow’s treatments.

“Advanced therapies represent a paradigm shift. They offer possibilities that were previously unimaginable,” stated Annika Östman Wernerson, President of Karolinska Institutet.

Throughout the day, ongoing research and breakthroughs were presented in cell and gene therapy, treatment of neonatal lung disease, Parkinson’s disease, and immunotherapies. The program highlighted the pioneering progress already being made within ATMP in Flemingsberg, where the center symbolizes a major investment in accelerating the work of future medicine even further. Knut Steffensen, Director of the Karolinska ATMP Center, summarized the vision:

“We will cure and alleviate tomorrow, what no one can cure and alleviate today.”

With the Karolinska ATMP Center now officially inaugurated, the work on future medicine takes a major step forward – where collaboration, knowledge, and compassion go hand in hand to give patients hope for a brighter future. At Flemingsberg Science Foundation, we are proud to have supported this important day for future medicine and treatments, and to celebrate all those working to drive progress forward.

The Life Science business of Merck KGaA, Darmstadt, Germany Becomes a Trusted Partner of the Flemingsberg Science Foundation

The Life Science business of Merck KGaA, Darmstadt, Germany, and Flemingsberg Science Foundation collaborate to promote Life Science sector in Flemingsberg. This strategic partnership aims to strengthen development of ATMP (Advanced Therapy Medicinal Products).

Alfa Laval strengthens Flemingsberg – establishes itself in a growing city of the future

In May 2025, Alfa Laval moved into its new office and innovation center, spanning approximately 20,000 square meters, together with around 700 employees. At the same time, the restaurant K-märkt opened, further expanding the range of services available in Flemingsberg. The Royal Swedish Opera and Dramaten, Alfa Laval, Restaurant Billmans, and K-märkt all represent important pieces of the puzzle in the development of Flemingsberg.

Touchdown Novum Labs for Hydromars!

A new company has arrived in Flemingsberg, and they´re moving at rocket speed on their journey toward space. Meet Hydromars, the startup company developing a system for water purification and nutrient recovery, with a grand goal of enabling sustainable human presence in space.

Previous 234 Next